SNTS Related Company Press Releases

Jun 18, 2013 01:00 AM Santarus and Pharming Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor) Biologics License Application

Jun 17, 2013 07:30 AM Santarus President & CEO Gerald Proehl Honored as San Diego Ernst & Young Entrepreneur of the Year 2013 in Life Sciences

May 17, 2013 07:00 AM Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting

May 15, 2013 04:05 PM Santarus Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering

May 10, 2013 09:04 AM Santarus Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder

May 9, 2013 04:01 PM Santarus Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder

May 6, 2013 04:05 PM Santarus Reports First Quarter 2013 Financial Results

May 3, 2013 07:00 AM Santarus to Present at May and June Investment Conferences

May 2, 2013 07:00 AM CYCLOSET (bromocriptine mesylate) Included in American Association of Clinical Endocrinologists Comprehensive Diabetes Management Algorithm

Apr 22, 2013 07:00 AM Santarus to Hold First Quarter 2013 Financial Results Conference Call on May 6